Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators (Q37132149)
Jump to navigation
Jump to search
scientific article published on 06 March 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators |
scientific article published on 06 March 2009 |
Statements
1 reference
Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators (English)
1 reference
Mark A Espeland
1 reference
Shalender Bhasin
1 reference
Jack Guralnik
1 reference
Luigi Ferrucci
1 reference
Stephanie Studenski
1 reference
Marco Pahor
1 reference
Susan Nayfield
1 reference
Linda P Fried
1 reference
Working Group on Functional Outcome Measures for Clinical Trials
1 reference
William J Evans
1 reference
Thomas M Gill
1 reference
Sergei Romashkin
1 reference
Robert Perlstein
1 reference
Laurie Burke
1 reference
Mary Parks
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference